Rationale and design of the PeriOperative ISchemic Evaluation-3 (POISE-3): A randomized controlled trial evaluating tranexamic acid and a strategy to minimize hypotension in noncardiac surgery
Background: For patients undergoing noncardiac surgery, bleeding and hypotension are frequent and associated with increased mortality and cardiovascular complications. Tranexamic acid (TXA) is an antifibrinolytic agent with the potential to reduce surgical bleeding; however, there is uncertainty abo...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Published: |
BMC
2022
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/33451/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|